Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Empagliflozin on Thioacetamide-Induced Liver Injury in Rats: Role of AMPK/SIRT-1/HIF-1α Pathway in Halting Liver Fibrosis
Authors
Keywords
-
Journal
Antioxidants
Volume 11, Issue 11, Pages 2152
Publisher
MDPI AG
Online
2022-10-30
DOI
10.3390/antiox11112152
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Potential Hepatoprotective Effect of Paeoniae Radix Alba in Thioacetamide-Induced Acute Liver Injury in Rats
- (2022) Mi-Rae Shin et al. Evidence-based Complementary and Alternative Medicine
- Modulatory Properties of Food and Nutraceutical Components Targeting NLRP3 Inflammasome Activation
- (2022) Mattia Spano et al. Nutrients
- SGLT-2 Inhibitors in NAFLD: Expanding Their Role beyond Diabetes and Cardioprotection
- (2022) Theodoros Androutsakos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Empagliflozin Reduces the Progression of Hepatic Fibrosis in a Mouse Model and Inhibits the Activation of Hepatic Stellate Cells via the Hippo Signalling Pathway
- (2022) Yu-Jung Heo et al. Biomedicines
- Promoted inhibition of TLR4/miR-155/ NFkB p65 signaling by Cannabinoid receptor 2 agonist (AM1241), aborts inflammation and progress of hepatic fibrosis induced by thioacetamide
- (2021) Alaa M. Ali et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
- (2021) Narjes Nasiri-Ansari et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro
- (2021) Ting Li et al. Frontiers in Pharmacology
- Dapagliflozin Alleviates Hepatic Steatosis by Restoring Autophagy via the AMPK-mTOR Pathway
- (2021) Liuran Li et al. Frontiers in Pharmacology
- Empagliflozin Improves Metabolic and Hepatic Outcomes in a Non-Diabetic Obese Biopsy-Proven Mouse Model of Advanced NASH
- (2021) Nikolaos Perakakis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of SGLT2 Inhibitors on Type 2 Diabetes Mellitus With Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials
- (2021) Qiong Wei et al. Frontiers in Endocrinology
- Hepatoprotective effects of gemigliptin and empagliflozin in a murine model of diet-induced non-alcoholic fatty liver disease
- (2021) Nami Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The involvement of TGF-β1 /FAK/α-SMA pathway in the antifibrotic impact of rice bran oil on thioacetamide-induced liver fibrosis in rats
- (2021) Rehab F. Abdel-Rahman et al. PLoS One
- Empagliflozin alleviates neuronal apoptosis induced by cerebral ischemia/reperfusion injury through HIF-1α/VEGF signaling pathway
- (2020) Rania G. Abdel-latif et al. ARCHIVES OF PHARMACAL RESEARCH
- Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
- (2020) Natascha Roehlen et al. Cells
- Relevance of SIRT1-NF-κB Axis as Therapeutic Target to Ameliorate Inflammation in Liver Disease
- (2020) Estefanía de Gregorio et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Effect of Empagliflozin on Liver Steatosis and Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease Without Diabetes: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2020) Hoda Taheri et al. ADVANCES IN THERAPY
- Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors
- (2020) Milton Packer Circulation-Heart Failure
- Sirt1-hypoxia-inducible factor-1α interaction is a key mediator of tubulointerstitial damage in the aged kidney
- (2019) Dong Ryeol Ryu et al. AGING CELL
- AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
- (2019) Qingguo Lu et al. BIOSCIENCE REPORTS
- Regression of fibrosis by cilostazol in a rat model of thioacetamide-induced liver fibrosis: Up regulation of hepatic cAMP, and modulation of inflammatory, oxidative stress and apoptotic biomarkers
- (2019) Sally A. El Awdan et al. PLoS One
- Propolis ameliorates cerebral injury in focal cerebral ischemia/reperfusion (I/R) rat model via upregulation of TGF-β1
- (2019) Rehab F. Abdel-Rahman et al. SAUDI PHARMACEUTICAL JOURNAL
- New Insights About Albumin and Liver Disease
- (2018) Joana R. Carvalho et al. Annals of Hepatology
- Antioxidant and anti-inflammatory activities of berberine attenuate hepatic fibrosis induced by thioacetamide injection in rats
- (2018) Laila Ahmed Eissa et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Mitochondria-derived ROS activate AMP-activated protein kinase (AMPK) indirectly
- (2018) Elizabeth C Hinchy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin inhibits mTOR-HIF-1α axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations
- (2018) Fahaid Al-Hashem et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Resveratrol prevents liver fibrosis via two possible pathways: Modulation of alpha fetoprotein transcriptional levels and normalization of protein kinase C responses
- (2017) AlyaaFarouk Hessin et al. INDIAN JOURNAL OF PHARMACOLOGY
- Amelioration of thioacetamide-induced liver toxicity in Wistar rats by rutin
- (2017) Seema Zargar et al. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY
- Naringin attenuates thioacetamide-induced liver fibrosis in rats through modulation of the PI3K/Akt pathway
- (2017) Kholoud Alaa El-Mihi et al. LIFE SCIENCES
- Polydatin attenuates potassium oxonate-induced hyperuricemia and kidney inflammation by inhibiting NF-κB/NLRP3 inflammasome activation via the AMPK/SIRT1 pathway
- (2017) Lvyi Chen et al. Food & Function
- Sodium glucose cotransporter 2 inhibition in the diabetic kidney
- (2016) Aleksandra Novikov et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Hypoalbuminemia and Osteoporosis: Reappraisal of a Controversy
- (2016) Farsad Afshinnia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sirtuins and nonalcoholic fatty liver disease
- (2016) Fatiha Nassir et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Empagliflozin (an SGLT2 inhibitor), alone or in combination with linagliptin (a DPP-4 inhibitor), prevents steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis and diabetes
- (2016) Teruo Jojima et al. Diabetology & Metabolic Syndrome
- Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction
- (2016) Chikara Komiya et al. PLoS One
- Influence of olive and rosemary leaves extracts on chemically induced liver cirrhosis in male rats
- (2015) Atef M. Al-Attar et al. SAUDI JOURNAL OF BIOLOGICAL SCIENCES
- Beneficial Effects of Canagliflozin in Combination with Pioglitazone on Insulin Sensitivity in Rodent Models of Obese Type 2 Diabetes
- (2015) Yoshinori Watanabe et al. PLoS One
- Oxidative stress as a crucial factor in liver diseases
- (2014) Halina Cichoż-Lach WORLD JOURNAL OF GASTROENTEROLOGY
- Role of the Hypoxia Inducible Factors HIF-1α and HIF-2α during hepatic repair in a rat model of thioacetamide (TAA)-induced chronic liver damage
- (2014) S Ahmad et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Animal models of chronic liver diseases
- (2012) Yan Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases
- (2012) Sung-Jun Park et al. CELL
- Weight Loss Induced by Chronic Dapagliflozin Treatment Is Attenuated by Compensatory Hyperphagia in Diet-Induced Obese (DIO) Rats
- (2012) James J. Devenny et al. Obesity
- AMPK and SIRT1: a long-standing partnership?
- (2010) Neil B. Ruderman et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The toxic effect of thioacetamide on rat liver in vitro
- (2010) Pavla Staňková et al. TOXICOLOGY IN VITRO
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now